Hepatocellular carcinoma: contrast enhancement with Levovist
- PMID: 11794406
- DOI: 10.7863/jum.2002.21.1.77
Hepatocellular carcinoma: contrast enhancement with Levovist
Abstract
Objective: To present the sonographic appearance of hepatocellular carcinoma imaged with the intravenous contrast agent Levovist.
Methods: We reviewed our experience using Levovist (Schering AG, Berlin, Germany) for the sonographic diagnosis of hepatocellular carcinoma.
Results: Contrast-enhanced sonography with Levovist facilitated detailed evaluation of tumor vascularity in hepatocellular carcinoma.
Conclusions: Contrast-enhanced sonography with Levovist enhances the role of sonography in the diagnosis of hepatocellular carcinoma. It provides detailed information about tumor vascularity and the contrast enhancement pattern.
Similar articles
-
Ultrasound contrast agent Levovist in colour Doppler sonography of hepatocellular carcinoma in Chinese patients.Australas Radiol. 1999 May;43(2):156-9. doi: 10.1046/j.1440-1673.1999.00627.x. Australas Radiol. 1999. PMID: 10901894 Clinical Trial.
-
Hepatocellular carcinoma: therapeutic experience with percutaneous ethanol injection under real-time contrast-enhanced color Doppler sonography with the contrast agent Levovist.J Ultrasound Med. 2002 Sep;21(9):1015-22. doi: 10.7863/jum.2002.21.9.1015. J Ultrasound Med. 2002. PMID: 12216749
-
Effectiveness of galactose-based intravenous contrast medium on color Doppler sonography of deeply located hepatocellular carcinoma.Ultrasound Med Biol. 1995;21(2):157-60. doi: 10.1016/s0301-5629(94)00122-7. Ultrasound Med Biol. 1995. PMID: 7571125 Clinical Trial.
-
[Contrast enhanced color Doppler sonogram of liver tumors: a color-filled pattern in the late phase].Nihon Rinsho. 1998 Apr;56(4):961-6. Nihon Rinsho. 1998. PMID: 9577617 Review. Japanese.
-
Contrast-enhanced sonography for hepatocellular carcinoma.Intervirology. 2004;47(3-5):162-8. doi: 10.1159/000078468. Intervirology. 2004. PMID: 15383725 Review.
Cited by
-
ctDNA as a novel and promising approach for cancer diagnosis: a focus on hepatocellular carcinoma.EXCLI J. 2023 Aug 3;22:752-780. doi: 10.17179/excli2023-6277. eCollection 2023. EXCLI J. 2023. PMID: 37720239 Free PMC article. Review.
-
Comparison of fundamental sonography, tissue-harmonic sonography, fundamental compound sonography, and tissue-harmonic compound sonography for focal hepatic lesions.Eur Radiol. 2006 Nov;16(11):2444-53. doi: 10.1007/s00330-006-0205-6. Epub 2006 Mar 29. Eur Radiol. 2006. PMID: 16570141
-
Diagnosis of hepatocellular carcinoma.HPB (Oxford). 2005;7(1):26-34. doi: 10.1080/13651820410024049. HPB (Oxford). 2005. PMID: 18333158 Free PMC article.
-
Radiofrequency ablation of liver cancer: early evaluation of therapeutic response with contrast-enhanced ultrasonography.Korean J Radiol. 2004 Jul-Sep;5(3):185-98. doi: 10.3348/kjr.2004.5.3.185. Korean J Radiol. 2004. PMID: 15467416 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
